Memphasys Limited (ASX:MEM)
Australia
· Delayed Price · Currency is AUD 0.0060
-0.0005 (-7.69%)
Mar 6, 2026, 2:41 PM AEST
Memphasys Revenue
Memphasys had revenue of 12.41K AUD in the half year ending December 31, 2025, a decrease of -96.36%. This brings the company's revenue in the last twelve months to 213.98K, up 52.11% year-over-year. In the fiscal year ending June 30, 2025, Memphasys had annual revenue of 526.92K with 237.77% growth.
Revenue (ttm)
213.98K
Revenue Growth
+52.11%
P/S Ratio
79.84
Revenue / Employee
8.92K
Employees
24
Market Cap
17.08M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 526.92K | 370.92K | 237.77% |
| Jun 30, 2024 | 156.00K | -468.37K | -75.01% |
| Jun 30, 2023 | 624.37K | 53.29K | 9.33% |
| Jun 30, 2022 | 571.08K | 359.60K | 170.04% |
| Jun 30, 2021 | 211.48K | - | - |
| Jun 30, 2020 | Pro | Pro | Pro |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CONNEQT Health | 5.80M |
| OncoSil Medical | 3.72M |
| Control Bionics | 6.07M |
| Adherium | 1.12M |
| CurveBeam AI | 12.15M |
| Atomo Diagnostics | 3.92M |
| ImpediMed | 14.23M |
| CleanSpace Holdings | 20.66M |